Coherus Oncology, Inc. CHRS

Set alert

Price alert · CHRS

All alert types
0.79 USD +0.04 +5.42%

As of Nov 3, 10:21 AM ET

Bid
0.79 × 3
Ask
0.79 × 2
0.77 Day range 0.8051
0.746 52-week range 2.62
YTD
-44.37%
1 year
-50.63%
Open
0.77
Prev close
0.7494
Mkt cap
122.06M
Vol
230.31K
Avg vol
1.45M
EPS
-1.25
P/E
0.00
Div yield
0.00%
More statistics
Low
0.77
High
0.8051
Forward P/E
-5.30
Beta
0.69
Short ratio
8.43
Inst. own
70.31%
Dividend
0.00
Ex-div date
50-d avg
1.10
200-d avg
1.56
1y target
5.90

1D chart

Chart tools
Interval

Signals (95)
NameTimeAgo
RSI: Oversold3:57 PM18 hours ago
SMA: Bearish3:55 PM18 hours ago
MACD: Sell Signal3:55 PM18 hours ago
SMA: Bearish3:54 PM18 hours ago
SMA: Bullish3:53 PM18 hours ago
SMA: Bearish3:50 PM18 hours ago
SMA: Bullish3:48 PM18 hours ago
SMA: Bearish3:47 PM18 hours ago
SMA: Bullish3:45 PM18 hours ago
SMA: Bullish3:44 PM18 hours ago
SMA: Bearish3:42 PM18 hours ago
SMA: Bearish3:42 PM18 hours ago
SMA: Bullish3:40 PM18 hours ago
SMA: Bullish3:40 PM18 hours ago
SMA: Bearish3:38 PM18 hours ago
SMA: Bearish3:38 PM18 hours ago
SMA: Bullish3:37 PM18 hours ago
SMA: Bullish3:37 PM18 hours ago
SMA: Bearish3:35 PM18 hours ago
SMA: Bearish3:35 PM18 hours ago

Newest 20 of 95.

Analyst view

Consensus: buy

Buy
Price target (mean) 5.90 +646.8% upside
Target (low)
1.50
Target (mean)
5.90
Target (high)
8.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 8
  • 2 months ago 9
  • 3 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CHRS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.12926-0.23 – 0.06469-0.6209+79.2%43.88M-52.1%5
Next quarter-0.0645-0.08 – -0.049-0.32+79.8%60.00M-22.1%2
Current year-0.64333-0.71 – -0.30081-1.98+67.6%255.58M-0.6%5
Next year0.00822-0.14 – 0.21288-0.64333+101.3%279.18M+9.2%4

Upgrades and downgrades

The latest rating changes

CHRS analyst upgrades and downgrades
DateFirmActionFromTo
Dec 5, 2024BairdMaintainedOutperformOutperform
Dec 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 8, 2024BairdMaintainedOutperformOutperform
Nov 7, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 16, 2024UBSDowngradeBuyNeutral
Aug 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 1, 2024BairdMaintainedOutperformOutperform
May 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2024Truist SecuritiesMaintainedBuyBuy
May 10, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 20, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 23, 2024BairdMaintainedOutperformOutperform
Jan 23, 2024Truist SecuritiesMaintainedBuyBuy
Dec 27, 2023HC Wainwright & Co.ReiteratedBuyBuy
Dec 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 28, 2023Truist SecuritiesReiteratedBuyBuy
Nov 17, 2023BairdInitiated—Outperform
Nov 8, 2023Maxim GroupDowngradeBuyHold
Nov 7, 2023HC Wainwright & Co.MaintainedBuyBuy
Oct 23, 2023BarclaysMaintainedOverweightOverweight
Sep 26, 2023Truist SecuritiesReiteratedBuyBuy
Sep 26, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 3, 2023HC Wainwright & Co.MaintainedBuyBuy
Jul 24, 2023CitigroupInitiated—Buy
Jul 14, 2023Truist SecuritiesMaintainedBuyBuy
Jun 28, 2023Truist SecuritiesReiteratedBuyBuy
Jun 20, 2023Truist SecuritiesMaintainedBuyBuy
Jun 20, 2023HC Wainwright & Co.ReiteratedBuyBuy